BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6984444)

  • 1. Ampicillin resistance in Haemophilus influenzae--test methods for the activity of acylureidopenicillins, cephamycins and new cephalosporins.
    Newsom SW; Matthews J
    J Antimicrob Chemother; 1982 Dec; 10(6):527-32. PubMed ID: 6984444
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.
    Mason EO; Kaplan SL; Anderson DC; Hinds DB; Feigin RD
    Antimicrob Agents Chemother; 1980 Mar; 17(3):470-3. PubMed ID: 6448579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
    Bergeron MG; Claveau S; Simard P
    Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Haemophilus influenzae to antibiotics.
    Williams JD; Andrews J
    Br Med J; 1974 Jan; 1(5899):134-7. PubMed ID: 4544225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
    Baker CN; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of 100 strains of Haemophilus influenzae exposed to 8 beta-lactam antibiotics].
    Torres Cid A; Benlloch Padilla M; Soriano García F
    Rev Clin Esp; 1982 Dec; 167(5):309-11. PubMed ID: 6984764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of PRSP and BLNAR].
    Hotomi M; Yamanaka N
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():441-7. PubMed ID: 17455659
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).
    Cordera CS; Pekarek RS
    Antimicrob Agents Chemother; 1980 Feb; 17(2):258-62. PubMed ID: 6446260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
    Connor E; Melick C; Yogev R
    J Antimicrob Chemother; 1982 Dec; 10(6):517-25. PubMed ID: 6298172
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
    Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S
    Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibiotic resistance: an always present problem].
    Debbia EA
    Recenti Prog Med; 1999 Oct; 90(10):505-9. PubMed ID: 10592734
    [No Abstract]   [Full Text] [Related]  

  • 13. The taxonomy and antimicrobial susceptibility of Haemophilus species in clinical specimens.
    Golberg R; Washington JA
    Am J Clin Pathol; 1978 Dec; 70(6):899-904. PubMed ID: 364976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin compared to ampicillin against Haemophilus influenzae and with other penicillins against intestinal aerobic Gram-negative rods.
    Chen HY; Williams JD
    J Antimicrob Chemother; 1982 Oct; 10(4):279-87. PubMed ID: 6982893
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins.
    García-de-Lomas J; Lerma M; Cebrián L; Juan-Bañón JL; Coronel P; Giménez MJ; Aguilar L
    Int J Antimicrob Agents; 2007 Aug; 30(2):190-2. PubMed ID: 17459665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
    Cisterna R; Fresnadillo MJ; García-Rodríguez JA; Gobernado M; Martín R; Perea E; Picazo J
    Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
    Seki H; Kasahara Y; Ohta K; Saikawa Y; Sumita R; Yachie A; Fujita S; Koizumi S
    Chemotherapy; 1999; 45(1):15-21. PubMed ID: 9876205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of antibacterial agents on Haemophilus influenzae isolates.
    Chugh TD; Neil L; Mahboob AG; Araj GF
    Trop Geogr Med; 1986 Dec; 38(4):404-7. PubMed ID: 3492795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance of bacteria--the present status and future prospect. 3. Haemophilus influenzae].
    Matsumoto K; Uzuka Y; Nagatake T; Taguchi M; Shishido H
    Nihon Rinsho; 1984 Mar; 42(3):664-70. PubMed ID: 6381803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.